371 related articles for article (PubMed ID: 35158828)
1. Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?
Gimeno-Valiente F; López-Rodas G; Castillo J; Franco L
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158828
[TBL] [Abstract][Full Text] [Related]
2. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
Narayanan SP; Singh S; Shukla S
Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
[TBL] [Abstract][Full Text] [Related]
3. Pharmaco-epigenomics: On the Road of Translation Medicine.
López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
[TBL] [Abstract][Full Text] [Related]
4. Advances in Epigenetic Cancer Therapeutics.
Hillyar C; Rallis KS; Varghese J
Cureus; 2020 Nov; 12(11):e11725. PubMed ID: 33391954
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
Biswas S; Rao CM
Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
[TBL] [Abstract][Full Text] [Related]
6. Regulation of alternative splicing: Functional interplay with epigenetic modifications and its implication to cancer.
Wang N; Hu Y; Wang Z
Wiley Interdiscip Rev RNA; 2023 Sep; ():e1815. PubMed ID: 37697868
[TBL] [Abstract][Full Text] [Related]
7. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
8. A-Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer.
Mohan N; Dashwood RH; Rajendran P
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539439
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of epigenetic mechanisms in cancer.
Maleszewska M; Wojtas B; Kamińska B
Postepy Biochem; 2018 Oct; 64(2):148-156. PubMed ID: 30656897
[TBL] [Abstract][Full Text] [Related]
10. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
Amirkhah R; Naderi-Meshkin H; Shah JS; Dunne PD; Schmitz U
Cells; 2019 Aug; 8(8):. PubMed ID: 31430887
[TBL] [Abstract][Full Text] [Related]
11. Mammalian epigenetic mechanisms.
Zhang G; Pradhan S
IUBMB Life; 2014 Apr; 66(4):240-56. PubMed ID: 24706538
[TBL] [Abstract][Full Text] [Related]
12. Connecting the dots: chromatin and alternative splicing in EMT.
Warns JA; Davie JR; Dhasarathy A
Biochem Cell Biol; 2016 Feb; 94(1):12-25. PubMed ID: 26291837
[TBL] [Abstract][Full Text] [Related]
13. Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets.
Javaid N; Choi S
Genes (Basel); 2017 Aug; 8(8):. PubMed ID: 28783137
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
15. Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer.
Liao W; Jordaan G; Srivastava MK; Dubinett S; Sharma S; Sharma S
Am J Cancer Res; 2013; 3(4):374-89. PubMed ID: 23977447
[TBL] [Abstract][Full Text] [Related]
16. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
Komar D; Juszczynski P
Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
18. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Toiyama Y; Okugawa Y; Goel A
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
[TBL] [Abstract][Full Text] [Related]
20. Epigenome engineering in cancer: fairytale or a realistic path to the clinic?
Falahi F; Sgro A; Blancafort P
Front Oncol; 2015; 5():22. PubMed ID: 25705610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
